Vitamin D regulates the phenotype of human breast cancer cells

Differentiation

Volumn 75, Issue 3, 2007, Pages 193-207

  Pendás Franco, Natalia ^a   González Sancho, José Manuel ^a   Suárez, Yajaira ^a   Aguilera, Oscar ^a   Steinmeyer, Andreas ^b   Gamallo, Carlos ^c   Berciano, María T ^d   Lafarga, Miguel ^d   Muñoz, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Research Business Area Dermatology   (Germany)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

1 ,25 dihydroxyvitamin D3; Breast cancer; Cadherins; Myoepithelial phenotype; 6 4 integrins

Indexed keywords

ALPHA5 INTEGRIN; BETA5 INTEGRIN; CADHERIN; CALCITRIOL; CLAUDIN 7; FOCAL ADHESION KINASE; LAMININ; NERVE CELL ADHESION MOLECULE; OCCLUDIN; PAXILLIN; UVOMORULIN; VITAMIN D; VITAMIN D RECEPTOR;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL COMMUNICATION; CELL INVASION; CELL MIGRATION; CELL SIZE; CELL SURVIVAL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOARCHITECTURE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ELECTRON MICROSCOPY; ENZYME PHOSPHORYLATION; FILOPODIUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LAMELLIPODIUM; MICROTUBULE; MOUSE; MYOEPITHELIUM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

MUS;

EID: 33947221529     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1111/j.1432-0436.2006.00131.x     Document Type: Article

References (55)

1. 3. Mol Endocrinol 7:1307-1312.
2. Beer, T.M., Eilers, K.M., Garzotto, M., Egorin, M.J., Lowe, B.A. and Henner, W.D. (2003) Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol 21:123-128.
3. 3 in breast cancer and relation to prognosis. Cancer Res 51:239-244.
4. 3 in normal human tissues. J Clin Endocrinol Metab 67:607-613.
5. Berman, A.E., Kozlova, N.I. and Morozevich, G.E. (2003) Integrins: structure and signalling. Biochemistry (Moscow) 68:1284-1299.
6. Boisvert, F.M., Hendzel, M.J. and Bazzett-Jones, D. (2000) Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 148:283-292.
7. Cavallaro, U., Schaffhauser, B. and Christofiori, G. (2002) Cadherins and the tumour progression: is it all in a switch? Cancer Lett 176:123-128.
8. 6 integrins to breast carcinoma survival and progression. Mol Cells 17:203-209.
9. Colston, K.W., Berger, U. and Coombes, R.C. (1989) Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1:188-191.
10. Colston, K.W. and Hansen, C.M. (2002) Mechanisms implied in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9:45-59.
11. Cross, H.S. (2005) Vitamin D and colon cancer. In: Feldman, D, Pike, J.W. and Glorieux, F.H. eds. Vitamin D. Elsevier Academic Press, Burlington, pp 1709-1725.
12. Dalhoff, K., Dancey, J., Astrup, L., Skovsgaard, T., Hamberg, K.J., Lofts, F.J.O., Rosmorduc, O., Erlinger, S., Bach Hansen, J., Steward, W.P., Skov, T., Burcharth, F. and Evans, T.R.J. (2003) A phase II trial of the vitamin D analogue seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer 89:252-257.
13. De Wever, O. and Mareel, M. (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447.
14. Erben, R.G., Soegiarto, D.W., Weber, K., Zuitz, U., Lieberherr, M., Gniadecki, R., Möller, G., Adamski, J. and Balling, R. (2002) Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and non-genomic functions of vitamin D. Mol Endocrinol 16:1524-1537.
15. 3 receptors in breast cancer and relationship to biochemical and clinical indices. Cancer Res 46:1677-1681.
16. Friedrich, M., Rafi, L., Mitschele, T., Tilgen, W., Schmidt, W. and Reichrath, J. (2003) Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Rec Res Cancer Res 164:239-246.
17. 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 55:901-906.
18. 4 signalling in lipid rafts. J Cell Biol 162:1189-1196.
19. Gordon, L.A., Mulligan, K.T., Maxwell-Jones, H., Adams, M., Walker, R.A. and Jones, J.L. (2003) Breast cell invasive potential relates to the myoepithelial phenotype. Int J Cancer 106:8-16.
20. Grant, W.B. (2002) An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94:272-281.
21. 3 analog. J Steroid Biochem Mol Biol 89-90:443-448.
22. Gumbiner, B. and Simmons, K. (1987) The role of uvomorulin in the formation of epithelial occluding junctions. Ciba Found Symp 125:168-186.
23. Hazan, R.B., Kang, L., Whooley, B.P. and Borgen, P.I. (1997) N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4:399-411.
24. Hazan, R.B., Phillips, G.R., Qiao, R.F., Norton, L. and Aaronson, S. (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779-790.
25. Hewison, M., Freeman, L., Hughes, S.V., Evans, K.N., Bland, R., Eliopoulos, A.G., Kilby, M.D., Moss, P.A. and Chakraverty, R. (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170:5382-5390.
26. Jones, C., Mackay, A., Grigoriadis, A., Cossu, A., Reis-Filho, J.S., Fulford, L., Dexter, T., Davies, S., Bulmer, K. and Ford, E., Parry, S., Buroni, M., Palmieri, G., Neville, A.M., O'Hare, M.J. and Lakhani, S.R. (2004) Expression profiling of purified normal luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res 64: 3037-3045.
27. Khanim, F.L., Gommersall, L.M., Wood, V.H., Smith, K.L., Montalvo, L., O'Neill, L.P., Xu, Y., Peehl, D.M., Stewart, P.M., Turner, B.M. and Campbell, M.J. (2004) Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene 23:6712-6725.
28. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 69:1399-1407.
29. Kovacs, A., Dhillon, J. and Walker, R.A. (2003) Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol 56:318-322.
30. Li, Y.C., Pirro, A.E., Amling, M., Delling, G., Baron, R., Bronson, R. and Demay, M.B. (1997) Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835.
31. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391-398.
32. Mercurio, A.M., Bachelder, R.E., Chung, J., O'Connor, K.L., Rabinovitz, I., Shaw, L.M. and Tani, T. (2001) Integrin laminin receptors and breast carcinoma progression. J Mammary Gland Biol 6:299-309.
33. 6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin Exp Metastasis 17:325-332.
34. 3 in mammary gland: from normal development to breast cancer. Steroids 66:301-308.
35. Nieman, M.T., Prudoff, R.S., Johnson, K.R. and Wheelock, M.J. (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147:631-643.
36. Ordóñez-Morán, P., Larriba, M.J., Pendás-Franco, N., Aguilera, O., González-Sancho, J.M. and Muñoz, A. (2005) Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 10:2723-2749.
37. Palacios, J., Benito, N., Pizarro, A., Suárez, A., Espada, J., Cano, A. and Gamallo, C. (1995) Anomalous expression of P-cadherin in breast carcinoma. Am J Pathol 146:605-612.
38. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signalling. J Cell Biol 154:369-387.
39. 3 in human colon cancer cells. Cancer Res 63:7799-7806.
40. Paredes, J., Albergaria, A., Oliveira, J.T., Jerónimo, C., Milanezi, F. and Schmitt, F.C. (2005) P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res 11:5869-5877.
41. Peräkylä, M., Malinen, M., Herzig, K.-H. and Carlberg, C. (2005) Gene regulatory potential of non-steroidal vitamin D receptor ligands. Mol Endocrinol 19:2060-2073.
42. Peralta Soler, A., Knudsen, K.A., Salazar, H., Han, A.C. and Keshgegian, A.A. (1999) P-cadherin expression in breast carcinoma indicates poor survival. Cancer 86:1263-1272.
43. Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H. and Akslen, L.A., Flunge, O., Pergamenschikov, A., Williams, C., Zhu, S.X., Lonning, P.E., Borreson-Dale, A.L., Brown, P.O. and Bostein, D. (2000) Molecular portraits of human breast tumors. Nature 406:747-752.
44. ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells. Oncogene 23:5532-5542.
45. Sørlie, T. (2004) Molecular portraits of breast cancer: tumor subtypes as distinct disease entities. Eur J Cancer 40:2667-2675.
46. Sørlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B., van de Rijn, M. and Jeffrey, S.S. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874.
47. Tong, D., Czerwenka, K., Sedlak, J., Schneeberger, C., Schiebel, A., Concin, N., Leodolter, S. and Zeillinger, R. (1999) Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Treat 56:91-97.
48. Tsuda, H., Takarabe, T., Hasegawa, F., Fukutomi, T. and Hirohashi, S. (2000) Large, central acellular zones indicating myoepithelial tumor differentiation in high grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. Am J Surg Pathol 24:197-202.
49. Vapociyan, A.A., Jones, M.L. andWard, P.A. (1993) Rapid analysis of leukocyte-endothelial adhesion. J Immunol Methods 159:93-100.
50. Welsh, J. (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 80:1721S-1724S.
51. 3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 83:85-92.
52. 3 results from ligand-induced stabilization. J Biol Chem 267:20082-20086.
53. 3 receptor ablation alters mammary gland morphogenesis. Development 129:3067-3076.
54. 3 receptor null mice. Mol Endocrinol 18:2208-2223.
55. Zinser, G.M. and Welsh, J. (2004b) Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 25:2361-2372.